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Abstract  
 Liver plays a significant role in glucose homeostasis and acts to 
retain normal glucose levels during fasting and in the postprandial period. 
The association between liver function tests and incidence of diabetes is not 
well established.  The present study was conducted to investigate the 
association between liver enzymes and diabetes, and to investigate the 
effects of the extract of U. pilulifera and metformin on liver enzymes. Study 
methodology included collection of U. pilulifera, preparation of its extract, 
induction of diabetic model through alloxan injection. Study findings showed 
a positive relationship between studied liver enzymes ALT, AST, and ALP 
and diabetes. Treating diabetic groups using either the extract of U. pilulifera 
or metformin showed protection potential for liver through restoring liver 
enzymes to levels approximate to control groups. Taken together,  the extract 
of U. pilulifera mimics the action of metformin in treating diabetes through 
restoring liver function tests to levels approximate to control group.  
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Introduction  
 Diabetes mellitus is a very wide prevalent disease in both developed 
and developing countries, and its world prevalence has been estimated as 
25% of the world population (Kavishankar et al., 2011). Diabetes mellitus 
results from disturbed carbohydrate metabolism, and this is associated with 
either insufficient blood insulin or insulin insensitivity (Maiti et al., 2004).  
 Irrespective to witnessing progress in treating diabetes using oral 
synthetic agents, there still a need to find out new medications because of the 
limitations of available  medications.  On the other hand, there is a need to 
formulate herbal plants with potential use as antidiabetic therapy (Wadkar et 
al., 2008).  
 Diabetes is not a single disease, but rather, a group of metabolic 
diseases. It  leads to diabetic complications. Antidiabetic herbs act through 
increasing insulin secretion, enhance glucose uptake by adipose or muscle 
tissues and inhibit glucose absorption from intestine and glucose production 
from liver (Hongxiang et al., 2009).   
 Metformin is an oral antidiabetic drug in the biguanide class. It is the 
first-line drug of choice for the treatment of type 2 diabetes, in particular, in 
overweight and obese people and those with normal kidney function. It is 
effective only in the presence of insulin. It does not directly stimulate insulin 
secretion. Its major effect is to increase insulin action. One important effect 
appears to be suppression of glucose output from the liver (Kavishankar et 
al., 2011). 
 Liver has a significant role in glucose homeostasis and acts to retain 
normal glucose levels during fasting and in the postprandial period 
(Duckworth, Hamel, Peavy, 1988).  The role of liver in developing of type 2 
diabetes has attracted much interest. Furthermore, it is thought that abnormal 
function of liver attributed to insulin-resistance syndrome may lead to 
development of type 2 diabetes (Marchesini et al., 2001). Liver function test 
is assessed through using liver enzymes aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), and alkaline phosphatase (ALP) (Hall and 
Cash, 2012). Both AST and ALT are considered markers of hepatocellular 
health. ALT is considered the most specific biomarker of liver pathology and 
is found mainly in liver (Lee et al., 2004). Because AST and ALP can be 
found in other tissues, they are thought to be less specific biomarkers of liver 
function (Lee et al., 2003). The relationship between concentrations of liver 
enzymes and the incidence of type 2 diabetes has been investigated through 
several studies. Some studies showed a significant relationship between 
serum AST and diabetes (Hanley et al., 2004; Nannipieri et al., 2005). Other 
studies have investigated the relationship between AST and ALT and risk of 
type 2 diabetes, with varied results (Doi et al., 2007; Goessling et al., 2008; 
Jiamjarasrangsi et al., 2008; Monami et al., 2008; Sato, Hayashi, Nadamura, 
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2008). Another study by Tibi et al (1988) showed that liver ALP was 
significantly higher in the diabetics compared with the control group.  
 Among well-known herbal plants of potential therapy for diabetes is 
Urtica pilulifera (Kavalali et al., 2003; Lopatkin et al., 2005;  Kavishankar et 
al., 2011; Irshaid and Mansi, 2009; Kavishankar et al., 2011; Shuwayeb and 
Khatib, 2013). Urtica pilulifera L. is one species of the family Urticaceae 
that has been  extensively cultivated in the Mediterranean region (Irshaid and 
Mansi, 2009; Shuwayeb and Khatib, 2013).  
 
Study objectives 
 The main objectives of the present study are to investigate the 
impacts of induced diabetes on liver function tests in liver of diabetic rats 
and to evaluate the effects of the extract of  U. pilulifera and metformin on 
liver function test. 
 
Methodology  
 Methodology followed in this study included the following steps: 
collection of U. pilulifera and preparation of its extracts, induction of 
diabetic model and biochemical evaluation of liver function tests. 
 
Collection of U. pilulifera and preparation of its extraction  
 U. pilulifera leaves were collected from appropriate areas at Jordan, 
air-dried in shade well-ventilated area and then ground into fine powder.  
About 350 g of powder was put in a Soxhlet cold  extractor using absolute 
methanol as solvent and remained for three consecutive days (Sadki et al., 
2001). The extract was concentrated to dryness in rotary evaporator under 
reduced pressure and controlled temperature (45°C) to yield an 11.4% 
viscous greenish-colored extract. The extract was kept at 4°C in a glass 
container until use. Wister rats were used in this study, in which their 
average weight was 170 g. The animals were carefully checked and 
monitored every day for any changes. After determination of  lethal dose 
(LD50), two doses were selected 1.25 g/kg and 1.88 g/kg of body weight. 
Doses were prepared through dissolving required amount of the viscous 
extract in 10 mL Tween-20: 0.9% NaCl (1:9, V/V).  
 
Diabetic model 
 Diabetes was induced employing alloxan so that rats were injected by 
alloxan monohydrate "B.O.H chemical LTD England" intraperitoneally  at a 
dose of 150 ml/kg body weight (dissolved in fresh normal saline) to 18 hr 
fasted rat. Rats were monitored for blood glucose and rats with blood 
glucose level over 200 mg/ml, were considered diabetic and employed in the 
study. 
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 Animals were assigned into the following groups:  
 Group I: control group; Group II: diabetic group; Group III: diabetic 
treated with 1.25 mg/kg of body weight; Group IV: diabetic treated with 1.88 
mg/kg of body weight. 
 
Evaluation of liver function tests 
 Liver function tests were evaluated using a commercial biochemistry 
analyzer (Roche 
 P800 MODULAR;  Roche Diagnostics, Indianapolis, IN, USA). 
 
Statistical analysis 
 Data analysis was carried out using SPSS 20. Data were presented as 
mean and standard deviation. T test was used to investigate the difference 
between liver enzymes in study groups. Significance level was considered at 
alpha level < 0.05.  
 
Study findings 
Concentrations of AST among study groups 
 As shown in table 1, concentration of AST in control group was 36.8 
+ 3.35 U/L, and this was significantly increased in diabetic group to 98.78 + 
12.82 (P <0.05). Treatment with the extract of U. pilulifera (1.25 mg/kg 
body weight) decreased the concentration of AST (43.46 + 3.48 U/L) 
significantly (P <0.05). Treatment with the extract of U. pilulifera (1.88 
mg/kg body weight) decreased the concentration of AST (51.53 + 4.62 U/L) 
significantly (P <0.05). Treatment with metformin (14.2 mg/kg body weight) 
decreased the concentration of AST (37.94 + 2.34 U/L) significantly (P 
<0.05). 
 
Concentrations of ALT among study groups 
 As shown in table 1, concentration of ALT in control group was 
46.93 + 7.32 U/L, and this was significantly increased in diabetic group to 
84.72 + 11.68 (P <0.05). Treatment with the extract of U. pilulifera (1.25 
mg/kg body weight) decreased the concentration of ALT (58.42 + 2.24 U/L) 
significantly (P <0.05). Treatment with the extract of U. pilulifera (1.88 
mg/kg body weight) decreased the concentration of ALT (51.62 + 3.25 U/L) 
significantly (P <0.05). Treatment with metformin (14.2 mg/kg body weight) 
decreased the concentration of ALT (47.82 + 2.17 U/L) significantly (P 
<0.05). 
 
Concentrations of ALP among study groups 
 As shown in table 1, concentration of ALP in control group was 
41.64 + 6.64 U/L, and this was significantly decreased in diabetic group to 
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35.73 + 2.13 (P <0.05). Treatment with the extract of U. pilulifera (1.25 
mg/kg body weight) increased the concentration of ALP (46.8 + 1.91 U/L) 
significantly (P <0.05). Treatment with the extract of U. pilulifera (1.88 
mg/kg body weight) increased the concentration of ALP (4.9.74 + 1.56 U/L) 
significantly (P <0.05). Treatment with metformin (14.2 mg/kg body weight) 
increased the concentration of ALP (46.72 + 4.59 U/L) significantly (P 
<0.05). 
Table 1: Concentration of liver enzymes among study groups 
Group Treatment  AST + SD 
(U/L) 
ALT + SD 
(U/L) 
ALP + SD 
(U/L) 
I Control  36.8 + 3.35  46.93 + 7.32 41.64 + 6.64 
II Diabetic  98.78 + 12.82 * 84.72 + 11.68 
* 
35.73 + 2.13 * 
III Diabetic treated with 1.25 
mg/kg 
43.46 + 3.48 ** 58.42+ 2.24 
** 
46.8 + 1.91 ** 
IV Diabetic treated with 1.88 
mg/kg 
51.53+ 4.62 ** 51.62 + 3.52 
** 
49.74 + 1.56 ** 
V Diabetic treated with 
metformin 14.2 mg/kg 
37.94 + 2.34 ** 47.82 + 2.17 
** 
46.72 + 4.59 ** 
* Compares diabetic group with control group 
** Compares treated groups with diabetic group 
 
Discussion 
 The present study was conducted to investigate  the impacts of 
diabetes on liver function tests in diabetic experimental model and to 
compare the effects of the extract of U.  pilulifera and metformin on liver 
function tests. 
 Liver function tests including AST, ALT and ALP were investigated 
among study groups. The data of the present study showed significant 
variations in liver function tests between control and diabetic groups. The 
findings of our study agree and confirm previous studies in which liver has a 
significant role in glucose homeostasis and acts to retain normal glucose 
levels (Duckworth, Hamel, Peavy, 1988). We agree with other studies that 
showed a role of liver in developing type 2 diabetes. Such studies proposed 
that abnormal function of liver attributed to insulin-resistance syndrome may 
lead to development of type 2 diabetes (Marchesini et al., 2001). However, 
liver function test is assessed through using liver enzymes aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), and alkaline 
phosphatase (ALP) (Hall and Cash, 2012). Our data are consistent with other 
studies in which AST and ALT were considered markers of hepatocellular 
health  (Lee et al., 2004). Our data also confirmed other previous studies that 
proved a significant relationship between concentrations of liver enzymes 
and the incidence of type 2 diabetes (Hanley et al., 2004; Nannipieri et al., 
2005). It is worth to mention that the relationship between AST and ALT and 
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risk of type 2 diabetes is not well established and our data did not agree with 
such studies (Doi et al., 2007; Goessling et al., 2008; Jiamjarasrangsi et al., 
2008; Monami et al., 2008; Sato, Hayashi, Nadamura, 2008). Our results 
showed that ALP was significantly decreased in diabetic group compared 
with control group (P <0.05), and this is not consistent with findings reported 
by Tibi et al (1988) who showed that liver ALP was significantly higher in 
the diabetics compared with the control group.  
 The data of this study revealed a significant role of the extract of U. 
pilulifera and metformin in restoring the liver function tests to levels 
approximates to control group. Within this context, it is plausible to share 
other researchers that there is a need to formulate herbal plants with potential 
use as antidiabetic therapy (Wadkar et al., 2008). It is also possible that the 
extract of U. pilulifera acts through increasing insulin secretion, enhance 
glucose uptake by adipose or muscle tissues and inhibit glucose absorption 
from intestine and glucose production from liver (Hongxiang et al., 2009). 
Our data showed that metformin has more profound effects in restoring liver 
function tests compared with the extract of U. pilulifera. This finding can be 
explained by taking into consideration the dose level since metformin 
concentration was higher than that of  U. pilulifera.  
 
Conclusion 
 The extract of U. pilulifera mimics the action of metformin in 
treating diabetes through restoring liver function tests to levels approximate 
to control group.  
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